High prevalence of dyslipidaemia despite adequate glycaemic control in patients with diabetes

Annals of the Academy of Medicine Singapore

Volumn 25, Issue 2, 1996, Pages 228-232

  Loh, K C ^a   Thai, A C ^b,d   Lui, K F ^c   Ng, W Y ^c  

^a TAN TOCK SENG HOSPITAL   (Singapore)

^b National University Hospital

^c NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^d NATIONAL UNIVERSITY HOSPITAL   (Singapore)

Author keywords

Cholesterol; Glycated haemoglobin; High density lipoprotein (HDL); Low density lipoprotein (LDL); Triglycerides; Very low density lipoprotein (VLDL)

Indexed keywords

ANTILIPEMIC AGENT; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD; CHI SQUARE DISTRIBUTION; DIABETES MELLITUS; FEMALE; HUMAN; HYPERLIPIDEMIA; INSULIN DEPENDENT DIABETES MELLITUS; MALE; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; PREVALENCE;

ADOLESCENT; ADULT; AGED; ANTILIPEMIC AGENTS; CHI-SQUARE DISTRIBUTION; CHOLESTEROL, HDL; CHOLESTEROL, LDL; CHOLESTEROL, VLDL; DIABETES COMPLICATIONS; DIABETES MELLITUS; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; HYPERLIPIDEMIAS; MALE; MIDDLE AGED; PREVALENCE; TRIGLYCERIDES;

EID: 0030096472     PISSN: 03044602     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Stern M P, Patterson J K, Haffner S M, Hazuda H P, Mitchell B D Lack of awareness and treatment of hyperlipidaemia in type II diabetes in a community survey. JAMA 1989; 262:360-4.
2. American Diabetes Association Consensus Statement. Detection and management of lipid disorders in diabetes. Diabetes Care 1993; 16(Suppl2): 106-12.
3. Friedewald W T, Levy R I, Fredrickson D S. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972; 18:499-502.
4. Grundy S M, Bilheimer D, Chait A, Clark L T, Denke M, Havel R J, et al. National cholesterol education program expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult treatment panel II). JAMA 1993; 269:3015-23.
5. Laws A, King A C, Haskell W L, Reaven G M Relation of fasting plasma insulin concentration to high density lipoprotein cholesterol and triglyceride concentrations in men. Arterioscler Thromb 1991; 11:1636-42
6. Lish H J, Sailer S. Lipoprotein patterns in diet, sulphonylurea, and insulin treated diabetes. Diabetologia 1981; 20:118-22.
7. Laakso M, Voutilainen E, SarLund H, Aro A, Pyorala K, Penttila I. Serum lipids and lipoproteins in middle-aged non-insulin-dependent diabetics. Atherosclerosis 1985; 56:271-81.
8. Billingham M S, Milles J J, Bailey C J, Hall R A. Lipoprotein subtraction composition in non-insulin-dependent diabetes treated by diet, sulphonylurea, and insulin. Metabolism 1989; 38:850-7.
9. Wilson P W F, Kannel W B, Anderson K M. Lipids, glucose intolerance and vascular disease: the Framingham study Monogr Atheroscler 1985; 13:1-11.
10. Brunzell J D, Hazzard W R, Matulsky A G, Bierman E L. Evidence for diabetes mellitus and genetic forms of hypertriglyceridaemia as independent entities Metabolism 1975; 24:1115-21.
11. Haffner S M, Stern M P, Hazuda H P, Mitchell B D, Patterson J K. Cardiovascular risk factors in confirmed prediabetics individuals: Does the clock for coronary heart disease start ticking before the onset of clinical diabetes? JAMA 1990; 263:2893-8.
12. Fredrickson D S, Lees R S. System for phenotyping hyperlipoprotemaemia. Circulation 1965; 31:321-7.
13. Manzato E, Zambon A, Lapolla A, Zambon S, Braghetto L, Crepaldi G, et al. Lipoprotein abnormalities in well-treated type II diabetic patients. Diabetes Care 1993, 16:469-75.
14. Fontbonne A, Eschwege E Insulin-resistance, hypertriglyceridaemia and cardiovascular risk: the Paris prospective study. Diabete Metab 1991, 17:93-5.
15. Assmann G, Schulte H. The role of triglycerides in coronary artery disease: lessons from the Prospective Cardiovascular Münster Study. Am J Cardiol 1992; 70:10H-13H.
16. Assmann G, Schulte H. Triglycerides and atherosclerosis: results from the Prospective Cardiovascular Münster Study. Atheroscler Rev 1991; 22:51-7.
17. Manninen V, Tenkanen L, Koskinen P, Huttunen J K, Manttari M, Hemonen O P, et al Joint effects of serum triglyceride and LDL and HDL cholesterol concentrations on coronary heart disease risk in Helsinki Heart Study implications for treatment. Circulation 1992, 85:37-45.
18. Reaven G M. Role of insulin resistance in human disease. Diabetes 1988; 37:1495-607.
19. Stern M P, Mitchell B D, Haffner S M, Hazuda H P. Does glycemic control of type II diabetes suffice to control diabetic dyslipidemia Diabetes Care 1992, 15:638-44.
20. Benzi L, Marchetti P, Giampietro O, Miccoli R, Pecori N, Sanna G, et al. Metabolic control affects plasma lipid and apolipoprotein levels in women, but not in men, with IDDM. Acta Diabetol 1988, 25:149-54.
21. Joven J, Vilella E, Costa B, Turner P R, Richart C, Masana L. Concentrations of lipids and apolipoproteins in patients with clinically well-controlled IDDM and NIDDM. Clin Chem 1989; 35:813-6.
22. Howard B V, Abbott W G H, Swinburn B A. Evaluation of metabolic effects of substitution of complex carbohydrates for saturated fat in individuals with obesity and NIDDM. Diabetes Care 1991; 14:786-95.
23. Simpson H C R, Carter R D, Lousley S, Mann J I. Digestible carbohydrate an independent effect on diabetic control in type 2 (non-insulin-dependent) diabetic patients? Diabetologia 1982; 23:235-9.
24. Rivellese A A, Giacco R, Genovese S, Patti L, Marotta G, Pacioni D, et al. Effects of changing amount of carbohydrate in diet on plasma lipoproteins and apolipoproteins in type II diabetic patients. Diabetes Care 1990, 13:446-8.
25. Castelli W P, Garrison R J, Wilson P W F. Incidence of coronary heart disease and lipoprotein cholesterol levels The Framingham Study. JAMA 1986; 256:2835-8.
26. Howard B V, Howard W J. Dy slipidaemia in non-insulin-dependent diabetes mellitus. Endocr Rev 1994; 15:263-74.